David Schaer
26Patents
5h-index
23Co-inventors
61Inventor score
Filing activity: May 28, 2015 → Mar 21, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10155818B2 | Anti-GITR antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 14 | Active |
| US10280226B2 | Anti-GITR antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 14 | Active |
| US10259882B2 | Anti-OX40 antibodies | Physics | 11 | Active |
| US10836830B2 | Antibodies and methods of use thereof | Chemistry; Metallurgy | 9 | Active |
| US10626181B2 | Nucleic acids encoding anti-OX40 antibodies | Physics | 5 | Active |
| US10144779B2 | Anti-CTLA-4 antibodies and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US10479833B2 | Anti-CTLA-4 antibodies and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US10912831B1 | Anti-CTLA-4 antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US10323091B2 | Anti-PD-1 antibodies and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US10577426B2 | Anti-GITR antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US11013802B2 | Anti-CTLA-4 antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US10800849B2 | Anti-GITR antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US11345755B2 | Anti-PD-1 antibodies and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US10829559B2 | Anti-GITR antibodies and methods of use thereof | Physics | 1 | Active |
| US11638755B2 | Anti-CTLA-4 antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11993653B2 | Antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11267889B2 | Anti-CTLA-4 antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11472883B2 | Methods of administering anti-OX40 antibodies | Physics | 0 | Active |
| US12246066B2 | Anti-CTLA-4 antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10450373B2 | Anti-PD-1 antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11136404B2 | Anti-OX40 antibodies | Physics | 0 | Active |
| US11401335B2 | Anti-GITR antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11332536B2 | Vectors comprising nucleic acids encoding anti-OX40 antibodies | Physics | 0 | Active |
| US11447557B2 | Antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11897962B2 | Anti-GITR antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.